Table 3 Characteristics of included studies
Author/year | Study type | Type of FCSEMS | Type of PCSEMS | Number of patients | Pre/post -Chemoradiotherapy | Dysphagia grade | Tumor location | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
FCSEMS | PCSEMS | PCSEMS | PCSEMS | FCSEMS | PCSEMS | FCSEMS | PCSEMS | ||||
Lárraga et al. [30]/2018 | Retrospective | SX- ELLA® (ELLA-CS, Hradec Králové, Czech Republic) | Ultraflex® NG, (Boston Scientific, Natick, Massachusetts, USA) | 21 | 29 | Pre: 12 (57.14%) Post: 13 (61.9%) | Pre: 12 (41.37%) Post: 13 (44.82%) | Grade 3: 10 (47.61%) Grade 4: 11 (52.38%) | Grade 3: 13 (44.82%) Grade 4: 16 (55.17%) | P: 1 (4.76%) M: 5 (23.8%) D&C: 15 (71.44%) | P: 1 (3.45%) M: 9 (31%) D&C: 19 (65.55%) |
Didden et al. [29]/2018 | RCT | WallFlex fully covered stent (Boston Scientific, Natick, Massachusetts, USA) | WallFlex partially covered stent (Boston Scientific, Natick, Massachusetts, USA) | 48 | 49 | Pre: 41 (85.41%) Post: 5 (10.41%) | Pre: 41 (85.41%) Post: 5 (10.41%) | 2.8 ± 0.7 | 2.8 ± 0.8 | P: 8 (16.67%) M: 13 (27.08%) D&C: 27 (56.25%) | P: 1 (20.4%) M: 8 (16.33%) D&C: 27 (55.1%) |
Persson et al. [28]/2017 | RCT | WallFlex fully covered stent (Boston Scientific, Natick, Massachusetts, USA) | Ultraflex® NG, (Boston Scientific, Natick, Massachusetts, USA) | 48 | 47 | NR | NR | 2 ± NR | 3 ± NR | NR | NR |
Verschuur et al. [27]/2008 | RCT | Niti-S stent (Taewoong Medical, Seoul, Korea) | Ultraflex® NG, (Boston Scientific, Natick, Massachusetts, USA) | 42 | 42 | Pre:11 (26.19%) Post: 15 (35.71%) | Pre:11 (26.19%) Post: 15 (35.71%) | 3 ± NR | 3 ± NR | M: 12 (28.57%) D&C: 30 (71.43%) | M: 10 (23.8%) D&C: 32 (71.43%) |
Homs et al. [26]/2004 | Prospective | Z-stent (Wilson-Cook Europe, Bjaeverskov, Denmark) | Ultraflex® NG, (Boston Scientific, Natick, Massachusetts, USA) And Flamingo Wallstent (Microvasive/Bos- ton Scientific) | 70 | Ultraflex:75 Flamingo:71 | Pre: 14 (20%) Post: 5 (7.14%) | Ultraflex: Pre: 17 (22.66%) Post: 6 (8%) Flamingo: Pre: 23 (32.4%) Post: 4 (5.63%) | 3.2 ± 0.5 | Ultraflex: 3 ± 0.7 Flamingo: 3.2 ± 0.5 | M: 12 (17.14%) D&C: 58 (82.85%) | Ultraflex: M: 15 (20%) D&C: 60 (80%) Flamingo: M: 14 (19.72%) D&C: 57 (80.28%) |